New directions for emerging therapies in acute myeloid leukemia: the next chapter

Conventional therapy for acute myeloid leukemia is composed of remission induction with cytarabine- and anthracycline-containing regimens, followed by consolidation therapy, including allogeneic stem cell transplantation, to prolong remission. In recent years, there has been a significant shift towa...

Descripción completa

Detalles Bibliográficos
Autores principales: Daver, Naval, Wei, Andrew H., Pollyea, Daniel A., Fathi, Amir T., Vyas, Paresh, DiNardo, Courtney D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599225/
https://www.ncbi.nlm.nih.gov/pubmed/33127875
http://dx.doi.org/10.1038/s41408-020-00376-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599225/
https://www.ncbi.nlm.nih.gov/pubmed/33127875
http://dx.doi.org/10.1038/s41408-020-00376-1

Ejemplares similares